Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4A | O75164 | 1/20 | 0.35 |
| ▸ | KDM4B | O94953 | 1/20 | 0.35 |
| ▸ | KDM5C | P41229 | 1/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.35 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.35 |
| ▸ | KDM3A | Q9Y4C1 | 1/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | LATS1 | O95835 | 6/20 | 0.31 |
| ▸ | LATS2 | Q9NRM7 | 4/20 | 0.31 |
| ▸ | LPL | P06858 | 2/20 | 0.30 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.30 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30728959 | 0.81 | NCF1 (0.42) | LPLLIPG | |
| SCHEMBL476912 | 0.81 | NCF1 (0.42) | LPLLIPG | |
| SCHEMBL16112595 | 0.76 | TLR8 (0.42) | — | |
| SCHEMBL13282636 | 0.76 | EGFR (0.35) | — | |
| SCHEMBL30543183 | 0.76 | NR4A2 (0.47) | — | |
| SCHEMBL17144060 | 0.76 | LPL (0.41) | LPLLIPG | |
| SCHEMBL7915830 | 0.76 | NR4A2 (0.47) | — | |
| SCHEMBL31620789 | 0.75 | LMNA (0.45) | LPLLIPG | |
| SCHEMBL16775396 | 0.75 | LMNA (0.45) | LPLLIPG | |
| SCHEMBL30074594 | 0.75 | EGFR (0.34) | LPLLIPGP2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11844268-B2 | Organic compound and organic light-emitting element | CANON KABUSHIKI KAISHA (JP) | 2023-12-12 | — | — | US | disclosed |
| US-11844268-B2 | Organic compound and organic light-emitting element | CANON KABUSHIKI KAISHA (JP) | 2023-12-12 | — | — | US | disclosed |
| US-20210143335-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11844268-B2 | Organic compound and organic light-emitting element | OR51E2, OR10J3, NR2E3 | KDM4A 4550/4885KDM4B 4754/4885KDM5C 4847/4885 |
| US-20210143335-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | OR51E2, OR10J3, NR2E3 | KDM4A 4550/4885KDM4B 4754/4885KDM5C 4847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.